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Factors determining renal response to water immersion in non-excretor
cirrhotic patients. Non-excretor cirrhotic patients, defined by their
inability to normally excrete a standard water load, display variable
responses to head—out water immersion. The hemodynamic, hormonal,
and renal functional status of fifteen such patients were analyzed
relative to water excretion during head—out water immersion. Group I
patients (N = 7) all excreted less than 40% of the water load during
immersion, whereas excretion was greater than 40% in all eight patients
in Group 2. Group 1 patients, when compared with Group 2, had more
ascites, more diuretic resistance, lower serum sodium concentration
(125 2 vs. 130 I mEq/liter, P < 0.05), and more impaired baseline
water excretion (12.9 1.2 vs. 35.9 5.9% of water load inS hr, P <
0.005). Systemic heinodynamic responses to water immersion were
similar in both groups. Glomerular filtration rate and renal plasma flow
were significantly more impaired in Group 1 patients (inulin clearance
28 6 vs. 62 9 ml/min/l.73 m2, P < 0.05; para-aminohippurate
clearance 212 35 vs. 357 37 mI/mm, P < 0.05). Concentrations of
plasma vasopressin(1.7 0.5 vs. 0.8 0.1 pg/mI, P <0.05), renin(8.6
1.7 vs. 3.8 0.9 ng/ml/hr, P < 0.05), aldosterone (82 14 vs. 39
10 ng/dl, P <0.05) and norepinephrine (1155 183 vs. 603 126 pg/mI,
P < 0.05) were all significantly higher in Group 1 than Group 2 patients
during water immersion. Thus, non-excretor cirrhotic patients are not
homogenous and appear to comprise a spectrum with those patients in
whom water excretion is most impaired, having tense ascites, diuretic
resistance, lower serum sodium concentrations, more impaired renal
function, and more marked abnormalities in the hormonal markers of
decreased effective blood volume.
Patients with cirrhosis have been shown to have impaired
sodium and water excretion [1—4], but this abnormality has not
been consistent [3, 4]. In a recent study, cirrhotic patients were
reported to be divisible into those who excreted a standard
intravenous 20 mI/kg water load normally (excretors) and
abnormally (non-excretors) [1]. The results of these studies
demonstrated that the non-excretor patients exhibited hor-
monal characteristics compatible with diminished effective
blood volume, including a significantly higher plasma renin,
aldosterone, norepinephrine and vasopressin concentrations
than the excretor patients [1]. The non-excretor patients also
exhibited more sodium retention, ascites, hyponatremia and
hypoalbuminemia. Head—out water immersion improved renal
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sodium and water excretion in these non-excretor patients [5,
61.
The purpose of the present study was to investigate further
the nature of the impaired water excretion in non-excretor
patients. In the present study, the hypothesis was further
examined that cirrhosis is associated with a continuum of
diminished effective blood volume and impaired water excre-
tion, which can be demonstrated beyond that described in the
previous study of excretor and non-excretor patients [1]. Spe-
cifically, the reasons for the often variable responses of cir-
rhotic patients to central blood volume expansion with
head—out water immersion have not been fully elucidated [3].
Fifteen non-excretor patients (<80% of an intravenous water
load excreted) were, therefore, studied in a prospective manner
to examine whether hormonal indices of a diminished effective
blood volume were significantly different in cirrhotic non-
excretor patients who, during immersion, excreted less than
40% of a water load versus those who excreted greater than
40% of a water load during immersion. This should be the case
if the response to an acute water load is an index of effective
blood volume in cirrhotic patients.
Methods
Fifteen patients (12 males and three females), aged 31 to 63
years, were admitted to the Clinical Research Center of the
University of Colorado Health Sciences Center. All had alco-
holic cirrhosis except for one woman in whom cirrhosis was
secondary to hepatitis B infection, and all manifested some
degree of ascites (that is, decompensation). Medications were
discontinued at least five days prior to study, and patients
ingested a 40 mEq sodium diet daily. Fluid intake was restricted
only if the plasma sodium concentration was below 125
mEq/liter. Informed consent was obtained and the protocol was
approved by the Human Subjects Committee. This study was
comprised of two phases in each patient; these phases were
performed in random order.
Phase I: Water load
Patients were awakened at 7:00 a.m. to void spontaneously.
They remained semi-recumbent for the duration of the test,
except when standing to void at hourly intervals. Intravenous
cannulae were placed in each forearm and loading doses of
para-aminohippuric acid (PAH, 0.08 mg/kg i.v.) and inulin (60
mg/kg i.v.) were then followed by a continuous intravenous
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infusion (30 ml/hr) of 5% dextrose solution containing inulin (60
mg/mi) and PAR (0.08 mg/mi).
After 10 mm of this sustaining infusion, the water load was
administered intravenously over 30 to 40 mm as 20 mllkg DW.
Hourly blood samples were taken from the contralateral fore-
arm for estimations of plasma sodium, osmolality, creatinine,
inulin, PAR, renin, aldosterone, norepinephrine, and vasopres-
sin. Hourly urine samples, always obtained after the corre-
sponding blood samples, were analyzed for sodium, osmolality,
inulin, PAR (17), and creatinine. Blood pressure was measured
hourly, using an arm cuff. The test was terminated 5 hr after
infusion of the water load, The results are expressed as the
percent water load excreted over 5 hr.
Phase 2: Water load during head—out water immersion
In this phase, the water loading procedure as described in
Phase 1 was repeated during head—out water immersion in a
temperature controlled steel tank at 35.5°C with the patient in a
semi-recumbent position, as previously described [5, 61. In 11
of the 15 patients, a Swan—Ganz catheter was placed via
percutaneous puncture of the basilic vein in the antecubital
fossa for measurements of right atrial (RAP), pulmonary artery
(PAP), and pulmonary wedge (PWP) pressures. Four patients
were studied in Group I and seven patients in Group 2. Pressure
recordings utilized a Gould—Statham P23 Id transducer and an
Electronic for Medicine VR6 Photographic recorder (White
Plains, New York, USA). Cardiac output (CO) was measured
using the thermodilution technique and a Model 9520 Edwards
Laboratories computer. Values for mean arterial pressure
(MAP), cardiac index (CI), and systemic vascular resistance
(SVR) were calculated by the standard formulae:
MAP (mm Hg) = 1/3 (systolic BP + 2 diastolic BP);
CI (liter/mm/rn2) = cardiac output (CO)/body surface area;
SVR (dynes. see em5) = 80 (MAP-RAP)/CO.
Pre-immersion measurements of CO, MAP, RAP, PAP,
PWP, and SVR were obtained in the semi-recumbent position
and repeated hourly during water immersion. All catheters were
removed at the end of the 5 hr test.
Biochemical measurements and determinations of renin,
aldosterone, norepinephrinc and vasopressin were performed
using the standard techniques previously described in this
laboratory [6]. Values reported for each hormone are the mean
of 5 hourly determinations during each water load.
On the basis of the percentage of water load excreted during
Phase 2, the patients were divided into two groups: Group 1,
N = 7, who excreted less than 40% of the administered water
load during 5 hr of immersion and Group 2, N = 8, who
excreted more than 40% of the water load during immersion
(Fig. 1).
Prior to study, all patients had been hospitalized for treat-
ment of ascites with bed rest and diuretics. Daily weights and
abdominal girths were available over seven to 14 days in all
patients; the patients were on similar diuretic regimens (Table
I), salt intakes (40 to 50 mEq/day) and bed rest regimens. The
ascites was graded in each patient on a I to 4 scale with 4+
indicating the most tense ascites.
Statistical analysis utilized paired or unpaired i-tests, as
appropriate. Results are given as mean standard error of the
mean (sEM). A P value less than 0.05 was considered statisti-
cally significant.
Fig. 1. Water load excretion during immersion. Patients were suhdi
vided into Group 1 (<40% excretion) and Group 2 (>40% excretion).
The patients in both groups were non-excretor before immersion since
all excreted less than 80% of the water load. However, as noted in
Figure 4, four patients excreted 80% or greater of the water load during
immersion.
Table 1. Clinical features
Group I Group 2
Age, years 55.1 3.6 46.3 3.1
Sex 2F, SM IF, 7M
Pulse 92±4 84±3
Systolic BP, mm Hg 111 6 112 4
Diastolic BP, mm Hg 74 3 69 3
Plasma albumin, gidI 2.5 0.2 2.8 0.2
Tense ascites, 4+ 7/7 1/8
Weight loss, kg/day 0.13 0.09 0.54 0.16 <0.05
Abdominal girth decrease, cm/day 0 0. I 1.0 0.3 <0.05
Daily dose, mg
Furosemide 68 32 67 59 NS
Spironolactone 254 37 221 53 NS
Results
Clinical features
The major pertinent clinical features of the patients are
summarized in Table 2. The slightly older age and higher pulse
rates in Group I patients were not statistically significant. Tense
ascites (4+) was a constant feature of the patients in Group 1,
whereas it was present in only one of the eight patients in Group
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Table 2. Diuretic responsiveness to identical regimens of bed rest,
sodium restriction, and furosemide and spironolactone
Group I Group 2 P value
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Table 3. Hemodynamic changes between control and immersion in Group I and Group 2 cirrhotic patients"
Group 1 Group 2*
Control Immersion P value Control Immersion P value
PWP
mm Hg
CI
lirer/min/m2
SVRdnes seccm
MAP
mmHg
11.8
3.78
973
86
16.1
4.7
750
83
<0.01
<0.05
<0.05
NS
8.1
4.2
921
114
83
14.9
5.1
692
81
<0.005
<0.005
<0.05
NS
a Abbreviations are: PWP, pulmonary wedge pressure; CI, cardiac index; SVR, systemic vascular resistance; MAP, mean arterial pressure.
Symbol is: * None of the changes from control to immersion in Group 1 were significantly different from the changes in Group 2.
In Table 1 are shown the diuretic responsiveness in both
patient groups. The doses of diuretic drugs were almost identi-
cal in both groups, but the response as assessed by weight loss
and decrease in abdominal girth was much less in patients in
Group I.
Laboratory data
Baseline serum sodium concentrations were significantly
lower in patients in Group 1 than Group 2 (125 2 vs. 130 1
mEq/liter, P < 0.05). Before immersion, water excretion was
also much lower in Group 1 than Group 2 patients (12.9 1.2
vs. 35.9± 5.9% over 5 hr, P < 0.005).
The effects of immersion on systemic hemodynamics in both
groups are shown in Table 3. As previously described 5, 61, CI
and PWP increased, SVR decreased and MAP was unaltered
during the maneuver. These control values and the value during
immersion were not significantly different between Group 1 and
Group 2 (Table 3). During control water loading, mean urinary
sodium excretion (UNUV) was 4.5 1.3 Eq/min in Group 1 and
10.9 3.5 jsEq/min in Group 2 (NS). During immersion,
however, Group 2 patients significantly increased UNaV (to 25.6
6.8 1aEqlmin, P < 0.02) whereas Group 1 patients did not (to
12.6 5.8, NS).
Inulin clearance, corrected for body surface area, was signif-
icantly lower in Group I than Group 2 patients, both during
control (28.3 6.1 vs. 62.1 8.6 mI/mm/I .73 m2, P < 0.05) and
immersion (34.1 7.8 vs. 79.6 13.5 ml/min/l.73 m2, P <0.05)
(Fig. 2). Simultaneous creatinine clearances demonstrated the
same changes during control (54.5 10.6 vs. 81.0 9.2 mI/mm,
P < 0.05) and immersion (63.9 10.4 vs. 98,4 11.8 mI/mm,
p < 0.05). The increase in inulin clearance with immersion was
statistically significant only in Group 2 (P < 0.05). Para-
aminohippurate clearances were also lower in Group I than
Group 2, both during control (212 35 vs. 357 37 mI/mm,
P < 0.02) and immersion studies (247 40 vs. 399 48 mI/mm,
P < 0.05) (Fig. 2). The renal vascular resistances were lower in
Group 2 than Group I patients during control (0.541 0.097 vs.
0.353 0.064) and immersion (0.246 0.026 vs. 0.225 0.038),
but these decreases were not statistically significant.
Control plasma vasopressin concentrations were significantly
higher in Group 1 than Group 2 (2.3 0.5 vs. 1.0 0.2 pg/mI,
P < 0.05). During water immersion, vasopressin was also
higher in Group I patients (1.7 0.5 vs. 0.8 01, P < 0.05)
(Fig. 3), and suppressed significantly during immersion only in
Group 2 patients (P < 0.02). Normal values for vasopressin in
a water—loaded subject are below the threshold sensitivity of
the assay (<0.5 pg/mI).
Control plasma renin activity was also significantly higher in
Group I patients as compared with Group 2 (11.6 2.5 vs. 4.9
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Fig. 2. Inulin (C1) and para-aminohippurate (PAH) clearances arc
lower in Group I than Group 2 decornpensated cirrhotic patients, both
during control and immersion. Group 2 patient's C10 was significantly
higher (P < 0.05) during immersion than control.
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1.2 ng/ml/hr, P < 0.05), and this difference was maintained
during immersion (8,6 1.7 vs. 3.8 0.9 ng/ml/hr, P < 0.05)
(Fig. 4). The suppression of renin with immersion reached
statistical significance only in Group 2 patients (P < 0.05).
Plasma aldosterone was not significantly different in the two
patient groups during the control studies, although plasma
aldostcrone concentrations tended to be higher in Group 1 (100
21 vs. 75 21 ng/dl, NS). During immersion, however,
plasma aldosterone concentrations were higher in Group 1
versus Group 2 (82 14 vs. 39 10 ng/dI, I' < 0.05) and only
the values in Group 2 suppressed during the immersion proce-
dure (P < 0.02).
Plasma norcpinephrine concentrations were not significantly
different in the two patient groups during the control studies
(1168 197 vs. 924 203 ng/ml, NS). During immersion,
however, plasma norepinephrine was significantly higher in
Group 1 than Group 2 patients (1155 183 vs. 603 126 pg/mI,
P < 0,05). Furthermore, only Group 2 patients exhibited a
significant suppression of plasma norepinephrine during immer-
sion (P < 0.02).
Discussion
In the present study, plasma hormone concentrations and
renal hemodynamics were demonstrated to be significantly
different in those non-excretor patients who excreted less than
40% of the water load during head—out water immersion (mean
21%) as compared to those who excreted greater than 40% of
the water load during immersion (mean 67%). Although four
patients of Group 2 increased their water excretion during
immersion to 80% or greater, all of the 15 patients excreted less
than 80% of the water load in the absence of immersion, that is,
all were non-excretors.
The present results as well as previous studies [18—20]
suggest that there may be continuum of impairment in water
excretion in cirrhotic patients beyond that previously described
[1]. In the earlier study [11, non-excretor patients (<80% of
water load excreted over 5 hr) demonstrated hormonal indices
of a decreased effective blood volume which were significantly
increased compared to excretor patients (>80% of water load
excreted over 5 hr). The present results extend these observa-
tions by further studying the characteristics of the non-excretor
patients during head—out water immersion. In contrast to Group
2 patients, the Group I patients who excreted a mean of 14%
before and 21% of the water load during immersion demon-
strated higher concentrations of plasma vasopressin, ream,
aldosterone, and norepinephrine, and failed to significantly
suppress the plasma level of these hormones during head—out
water immersion. These cirrhotic patients also were more
hyponatremic; they demonstrated clinically tense ascites, and
were diuretic—resistant. The Group 1 patients also demon-
strated significantly lower clearances of inulin and para-
aminohippurate in spite of comparable mean arterial pressures
and cardiac indices. The increased renal vascular resistance and
diminished renal hemodynamics were associated with higher
plasma concentrations of renin, norepincphrine and vasopres-
sin in the Group 1 patients. The decreased renal hemodynamics
as well as the elevated concentrations of vasopressin and
aldosterone were no doubt involved in the more profound
impairment in renal excretion of sodium and water in the Group
I as compared to the Group 2 patients,
Since mean blood pressures and cardiac indices were com-
parable in Groups I and 2, the explanation for the differences in
renal hemodynamics and plasma hormone levels is intriguing.
Since cardiac output was not lower in the Group 1 patients,
caval compression secondary to their more tense ascites with a
resultant decrease in venous return and cardiac output, did not
account for the greater renal excretory impairment of' the Group
I patients [7, 81. The present findings are compatible, however,
with differences in the degree of diminished effective blood
volume in the non-excretor cirrhotic patients in Group I and
Group 2. In a recent study of cirrhotic patients from our
laboratory, the level of peripheral vascular resistance was
found to he a very important determinant of effective blood
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Fig. 3. Plasma arginine vasopressin (A VP) levels are higher in Group
1 than Group 2 decornpensa led cirrhotic patients, hot/i during control
and immersion, The AVP values in Group 2 were significantly lower
during immersion than the control period (P < (1.02).
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Fig. 4. Plasma renin activity (PRA) is significantly higher in Group 1
than Group 2 patients, both with and without immersion, The PRA in
Group 2 were significantly lower during immersion than during the
control period (P < 0.05).
Variable response to immersion in cirrhosis 421
volume 16]. In this regard, the present results are compatible
with the concept of a greater initial peripheral vasodilation in
the Group I patients during an earlier phase of their liver
disease, and thus a more profound diminution in effective blood
volume. In response to this greater circulatory inadequacy,
increased sympathetic activity, activation of the renin—angi-
otensin system, and the nonosmotic release of vasopressin
would be expected to occur. This sequence of events might then
act to restore peripheral vascular resistance and blood pressure
toward pre-cirrhotic levels, but at the same time lead to severe
renal vasoconstrietion and more avid retention of sodium and
water [10, 11]. This interpretation is compatible with the higher
plasma cocentrations of vasopressin, renin and norepinephrine
and renal vascular resistance in the Group 1 patients, even
though the systemic vascular resistances were comparable in
the two groups. Similar increases in renal vascular resistance
and sodium retention have been demonstrated in experimental
arteriovenous fistulae [12]. In the steady—state condition, the
cardiac index would be expected to be comparable in Groups 1
and 2, since the after load, as determined by peripheral vascular
resistance, would be comparable in both groups. The present
results are most compatible with this interpretation; however,
patients with cirrhosis will need to be followed longitudinally in
order to document definitively this proposed sequence of
events.
Finally, there are several potential clinical implications aris-
ing from the present study. It would seem likely that the
hyponairemic, diuretic—resistant cirrhotic patients with tense
ascites (Group 1) are the most likely patients to progress to the
state of hepatorenal syndrome. The much lower glomerular
filtration rates and renal plasma flows in these Group 1 patients
occurred in spite of comparable mean arterial pressures in both
groups, indicating higher levels of renal vascular resistance in
the Group I patients. Their higher and non-suppressible plasma
levels of norepinephrine, renin and vasopressin are compatible
with a role for the sympathetic nervous system, angiotensin,
and vasopressin in mediating this higher level of renal vascular
resistance. Thus, the patients in Group 1 might also be expected
to experience a more profound lowering of blood pressure
during alpha—adrenergie blockade [13], angiotensin antagonism
[14, 211, and inhibition of the vascular effect of vasopressin (15).
Furthermore, these diuretic resistant Group I patients may be
potential candidates for peritoneovenous (LeVeen) shunting as
a means to increase effective blood volume and improve renal
excretory function [16]. In this regard, in a recent preliminary
follow—up report on the present patients 1221, Group I patients
exhibited a significantly higher morbidity and mortality than the
Group 2 patients. One palient in Group I, however, received a
LeVeen shunt and normalized his water excretion and was the
only patient in this group to live longer than five months; he is
still alive at 24 months. The Group 2 patients' survival is
presently beyond an average of 28 months.
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